Fitbug Holdings PLC Share Option Schemes & Grant of Options (1077F)
July 25 2016 - 2:45AM
UK Regulatory
TIDMFITB
RNS Number : 1077F
Fitbug Holdings PLC
25 July 2016
Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector:
Leisure
25 July 2016
FITBUG HOLDINGS PLC ('FITBUG' OR 'THE COMPANY')
Adoption of Share Option Schemes and Grant of Options
Fitbug Holdings Plc, the AIM quoted technology developer and
digital wellness pioneer, is pleased to announce that, as set out
in the Circular to shareholders on 29 June 2016, following
admission of its enlarged issued share capital to trading on AIM
this morning, it has adopted two new share option schemes, the
Fitbug Holdings plc Enterprise Management Incentive Share Option
Scheme 2016 and the Fitbug Holdings plc Unapproved Share Option
Scheme 2016, for directors, employees, and certain other persons
engaged in the business of the Group (the "New Schemes").
The Company has also granted options over an aggregate of
113,837,413 Ordinary Shares, representing 9.24% of the enlarged
issued share capital of the Company pursuant to the New Schemes.
The options are all exercisable between the third and tenth
anniversary of grant or in the event of a takeover. One third of
the options held by each option holder will be exercisable at 0.25p
per share, one third at 0.35p per share and the remainder at 0.5p
per Ordinary Share.
Options granted to the directors and other persons discharging
managerial responsibilities are as follows:
Name Options Options Options Total Percentage
issued issued issued number of enlarged
at 0.25p at 0.35p at 0.5p of options issued
exercise exercise exercise held share
price price price capital
----------------- ----------- ----------- ----------- ------------ -------------
Donald
Stewart 4,925,468 4,925,468 4,925,468 14,776,404 1.2%
----------------- ----------- ----------- ----------- ------------ -------------
Anna Gudmundson 18,470,505 18,470,505 18,470,505 55,411,514 4.5%
----------------- ----------- ----------- ----------- ------------ -------------
Tyler Tarr 3,694,101 3,694,101 3,694,101 11,082,303 0.9%
----------------- ----------- ----------- ----------- ------------ -------------
Mark Ollila 3,694,101 3,694,101 3,694,101 11,082,303 0.9%
----------------- ----------- ----------- ----------- ------------ -------------
Richard
Goodlad 3,694,101 3,694,101 3,694,101 11,082,303 0.9%
----------------- ----------- ----------- ----------- ------------ -------------
Total 34,478,275 34,478,275 34,478,275 103,434,825 8.4%
----------------- ----------- ----------- ----------- ------------ -------------
**ENDS**
Anna Gudmundson Fitbug Holdings
/ Donald Stewart Plc 020 7449 1000
----------------------- ------------------------ --------------
Cantor Fitzgerald
Marc Milmo/ Catherine Europe, Nomad
Leftley and Joint Broker 020 7894 7000
----------------------- ------------------------ --------------
Claire Louise Noyce
/ William Lynne Hybridan LLP,
/ Niall Pearson Joint Broker 020 3764 2341
----------------------- ------------------------ --------------
Elisabeth Cowell St Brides Partners
/ Charlotte Heap Ltd, Public Relations 020 7236 1177
----------------------- ------------------------ --------------
Notes
About Fitbug(R)
Fitbug is a leading provider of online health and well-being
services which is pioneering an innovative 'Digital Wellness' model
to help individuals to improve their lifestyles by making realistic
changes to their daily routine. It combines activity tracking
devices, which provide an understanding of each user's daily
activity achievements, with mobile and web technology, which
provides users with personalised weekly activity and nutrition
targets, feedback, advice and encouragement to achieve "wellness".
This is centred on four key areas: stress, sleep, nutrition and
activity.
Its "Kiqplan"TM digital health coaching platform is designed to
make wearable technology relevant to new audiences and take the "so
what?" out of activity tracking by providing structured action
plans to help people achieve their wellness goals.
The Company is primarily focussed on the B2B market, mainly
mid-to-large cap corporations and insurance brokers / health
insurers, where significant growth opportunities have been
identified, particularly in the UK and US. An important part of the
Company's focus is on building strategic relationships with
organisations, which can integrate Fitbug or Kiqplan into their own
service/product offerings or resell to their customer base. For
more information, visit www.fitbug.com and www.kiqplan.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPGUPCMUPQUMA
(END) Dow Jones Newswires
July 25, 2016 03:45 ET (07:45 GMT)
Kin (LSE:KIN)
Historical Stock Chart
From Apr 2024 to May 2024
Kin (LSE:KIN)
Historical Stock Chart
From May 2023 to May 2024